<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02294097</url>
  </required_header>
  <id_info>
    <org_study_id>WWC-005</org_study_id>
    <nct_id>NCT02294097</nct_id>
  </id_info>
  <brief_title>Protocol-Specified Modification of Immunosuppression Directed to Protocol Biopsy in Kidney Transplantation</brief_title>
  <official_title>The Outcomes of Protocol-Specified Modification of Immunosuppression Directed to Histological Diagnosis by Surveillance Protocol Biopsy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chulalongkorn University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chulalongkorn University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The risk-benefit of surveillance-protocol biopsy (SPBx) in kidney transplantation remains
      unclear. The study aims to compare outcomes of recipients with SPBx approach to recipients
      with standard approach which allograft biopsy was performed only when indicated.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The present randomized-controlled trial in kidney transplant patients aims to compare the
      outcomes and complications between who underwent immunosuppessive drug modification under
      surveillance-protocol biopsy and who underwent immunosuppressive drug modification following
      tough level only.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2014</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Renal function</measure>
    <time_frame>24 months</time_frame>
    <description>24 h-CrCl</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Renal pathology</measure>
    <time_frame>24 months</time_frame>
    <description>interstitial fibrosis, rejection, calcineurin inhibitor toxicity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>immediate, 1 month</time_frame>
    <description>hematoma, arteriovenous fistula</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Surveillance Protocol Biopsy</condition>
  <arm_group>
    <arm_group_label>Non-biopsy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Population in this arm will be adjusted immunosuppressive drug only from the result of tough level.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Protocol biopsy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Population in this arm will be adjusted immunosuppressive drug upon both pathological findings and the result of tough level.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Surveillance protocol kidney allograft biopsy</intervention_name>
    <description>Surveillance protocol biopsy under ultrasound-guided will perform at post-operative day 7, month 3, month 6, month 12, and month 24</description>
    <arm_group_label>Protocol biopsy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All kidney transplant recipients underwent transplantation at Chulalongkorn University

        Exclusion Criteria:

          -  Pregnancy

          -  Recipients who cannot withhold aspirin, clopidogrel, warfarin, etc.

          -  Non-cooperated recipients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>17 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wiwat Chancharoenthana, MD.,MSc.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chulalongkorn University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wiwat Chancharoenthana, MD., MSc.</last_name>
    <phone>+66 22564251</phone>
    <phone_ext>101</phone_ext>
    <email>wiwatmd@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University</name>
      <address>
        <city>Bangkok</city>
        <zip>10330</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wiwat Chancharoenthana, MD, MSc</last_name>
      <email>wiwatmd@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 15, 2014</study_first_submitted>
  <study_first_submitted_qc>November 15, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 19, 2014</study_first_posted>
  <last_update_submitted>November 15, 2014</last_update_submitted>
  <last_update_submitted_qc>November 15, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 19, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chulalongkorn University</investigator_affiliation>
    <investigator_full_name>Wiwat Chancharoenthana</investigator_full_name>
    <investigator_title>Chulalongkorn University</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

